SPRED1 and Legius syndrome: SPRED1 is a negative regulator of the RAS–MAPK signaling pathway downstream of receptor tyrosine kinase signaling (Wakioka et al, 2001), and germline loss-of-function mutations in SPRED1 cause neurofibromatosis 1-like syndrome in humans (Brems et al, 2007).